These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37756247)

  • 81. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Surfactant therapy for acute lung injury and acute respiratory distress syndrome.
    Raghavendran K; Willson D; Notter RH
    Crit Care Clin; 2011 Jul; 27(3):525-59. PubMed ID: 21742216
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group.
    Verder H; Robertson B; Greisen G; Ebbesen F; Albertsen P; Lundstrøm K; Jacobsen T
    N Engl J Med; 1994 Oct; 331(16):1051-5. PubMed ID: 8090164
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The significance of recurrent lung opacities in neonates on surfactant treatment for respiratory distress syndrome.
    Odita JC
    Pediatr Radiol; 2001 Feb; 31(2):87-91. PubMed ID: 11214692
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparing the clinical and economic efficiency of four natural surfactants in treating infants with respiratory distress syndrome.
    Izadi R; Shojaei P; Haqbin A; Habibolahi A; Sadeghi-Moghaddam P
    PLoS One; 2023; 18(6):e0286997. PubMed ID: 37390082
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Risk factors of the failure of surfactant treatment by transient intubation during nasal continuous positive airway pressure in preterm infants.
    Cherif A; Hachani C; Khrouf N
    Am J Perinatol; 2008 Nov; 25(10):647-52. PubMed ID: 18841536
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Efficacy of different preparations of budesonide combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome: a comparative analysis].
    Ke H; Li ZK; Yu XP; Guo JZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 May; 18(5):400-4. PubMed ID: 27165587
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Doppler-derived systolic pulmonary artery pressure in acute neonatal respiratory distress syndrome.
    Seppänen MP; Kääpä PO; Kero PO; Saraste M
    Pediatrics; 1994 May; 93(5):769-73. PubMed ID: 8165076
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.
    Bhutani VK; Abbasi S; Long WA; Gerdes JS
    J Pediatr; 1992 Feb; 120(2 Pt 2):S18-24. PubMed ID: 1735846
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 92. HFOV vs CMV for neonates with moderate-to-severe perinatal onset acute respiratory distress syndrome (NARDS): a propensity score analysis.
    Liu K; Chen L; Xiong J; Xie S; Hu Y; Shi Y
    Eur J Pediatr; 2021 Jul; 180(7):2155-2164. PubMed ID: 33638098
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Ultrasound-assessed lung aeration correlates with respiratory system compliance in adults and neonates with acute hypoxemic restrictive respiratory failure: an observational prospective study.
    Biasucci DG; Loi B; Centorrino R; Raschetti R; Piastra M; Pisapia L; Consalvo LM; Caricato A; Grieco DL; Conti G; Antonelli M; De Luca D
    Respir Res; 2022 Dec; 23(1):360. PubMed ID: 36529748
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Comparison of the effect of surfactant administration during nasal continuous positive airway pressure with that of nasal continuous positive airway pressure alone on complications of respiratory distress syndrome: a randomized controlled study.
    Nakhshab M; Tajbakhsh M; Khani S; Farhadi R
    Pediatr Neonatol; 2015 Apr; 56(2):88-94. PubMed ID: 25264154
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pharmaceutical Expenditure Is Unchanged with Ultrasound-Guided Surfactant Administration.
    De Luca D; Yousef N
    Am J Perinatol; 2022 Apr; 39(5):562-566. PubMed ID: 32819020
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Acute effects of instillation of surfactant in severe respiratory distress syndrome.
    Halliday HL; McCord FB; McClure BG; Reid MM
    Arch Dis Child; 1989 Jan; 64(1 Spec No):13-6. PubMed ID: 2647040
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Implementation of a standardized lung ultrasound protocol for respiratory distress in a neonatal intensive care unit: an observational study.
    Firszt O; Grabowska A; Saran A; Kluczewska E
    J Perinatol; 2024 Sep; 44(9):1264-1268. PubMed ID: 38361003
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Lung ultrasound as a non-invasive tool for respiratory distress syndrome.
    Bhatia A; Saxena AK; Sodhi KS
    Acta Paediatr; 2021 May; 110(5):1682. PubMed ID: 33377222
    [No Abstract]   [Full Text] [Related]  

  • 99. The use of lung ultrasound in neonatal units and the importance of critical revision of published data.
    Alonso-Ojembarrena A; De Luca D; Raimondi F
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2371541. PubMed ID: 38937118
    [No Abstract]   [Full Text] [Related]  

  • 100. European Consensus Guidelines on the Management of Respiratory Distress Syndrome, 2022 : What is New?
    Upadhyay A; Anand P
    Indian Pediatr; 2023 Dec; 60(12):1035-1038. PubMed ID: 38087788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.